ArticleAntimicrobial agents and chemotherapy2012

MBX-500, a hybrid antibiotic with in vitro and in vivo efficacy against toxigenic Clostridium difficile.

Michelle M Butler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.